What was meant to be a patient-focused program is now a hospital markup program where large, tax-exempt hospital systems buy discounted drugs, mark them up by as much as 1,000% or more and bill patients and insurers the list price.
Harry Gewanter
Dr. Harry Gewanter is a Richmond-based rheumatologist and president of the Virginia Society of Rheumatology.
Posted inCardinal Way
Governor Youngkin should veto Prescription Drug Affordability Boards, again
Other states with PDABs in operation showcase this concept’s inability to lower patient prices.
Posted inOpinion
Gov. Youngkin, please veto the Prescription Drug Affordability Board legislation
The bill could make it difficult to obtain some medications.
